Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Major Pharmaceuticals recalls Levothyroxine Sodium Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Subpotent Drug
Products
  • Levothyroxine Sodium Tablets
Where it was sold

Nationwide in the USA.

Nationwide

Units affected
N/A
About this recall
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6952-61